Literature DB >> 21126580

Receptor protein tyrosine phosphatases are novel components of a polycystin complex.

Catherine A Boucher1, Heather H Ward, Ruth L Case, Katie S Thurston, Xiaohong Li, Andrew Needham, Elsa Romero, Deborah Hyink, Seema Qamar, Tamara Roitbak, Samantha Powell, Christopher Ward, Patricia D Wilson, Angela Wandinger-Ness, Richard N Sandford.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutation of PKD1 and PKD2 that encode polycystin-1 and polycystin-2. Polycystin-1 is tyrosine phosphorylated and modulates multiple signaling pathways including AP-1, and the identity of the phosphatases regulating polycystin-1 are previously uncharacterized. Here we identify members of the LAR protein tyrosine phosphatase (RPTP) superfamily as members of the polycystin-1complex mediated through extra- and intracellular interactions. The first extracellular PKD1 domain of polycystin-1 interacts with the first Ig domain of RPTPσ, while the polycystin-1 C-terminus of polycystin-1 interacts with the regulatory D2 phosphatase domain of RPTPγ. Additional homo- and heterotypic interactions between RPTPs recruit RPTPδ. The multimeric polycystin protein complex is found localised in cilia. RPTPσ and RPTPδ are also part of a polycystin-1/E-cadherin complex known to be important for early events in adherens junction stabilisation. The interaction between polycystin-1 and RPTPγ is disrupted in ADPKD cells, while RPTPσ and RPTPδ remain closely associated with E-cadherin, largely in an intracellular location. The polycystin-1 C-terminus is an in vitro substrate of RPTPγ, which dephosphorylates the c-Src phosphorylated Y4237 residue and activates AP1-mediated transcription. The data identify RPTPs as novel interacting partners of the polycystins both in cilia and at adhesion complexes and demonstrate RPTPγ phosphatase activity is central to the molecular mechanisms governing polycystin-dependent signaling. This article is part of a Special Issue entitled: Polycystic Kidney Disease.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126580      PMCID: PMC3156852          DOI: 10.1016/j.bbadis.2010.11.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  98 in total

1.  The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro.

Authors:  S C Parnell; B S Magenheimer; R L Maser; C A Rankin; A Smine; T Okamoto; J P Calvet
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

2.  The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.

Authors:  M J Wallace; C Fladd; J Batt; D Rotin
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

3.  Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene.

Authors:  Lukas Foggensteiner; A Paul Bevan; Ruth Thomas; Nicholas Coleman; Catherine Boulter; John Bradley; Oxana Ibraghimov-Beskrovnaya; Katherine Klinger; Richard Sandford
Journal:  J Am Soc Nephrol       Date:  2000-05       Impact factor: 10.121

4.  Polycystin expression is temporally and spatially regulated during renal development.

Authors:  J Van Adelsberg; S Chamberlain; V D'Agati
Journal:  Am J Physiol       Date:  1997-05

5.  Distinct and common developmental expression patterns of the murine Pkd2 and Pkd1 genes.

Authors:  R Guillaume; M Trudel
Journal:  Mech Dev       Date:  2000-05       Impact factor: 1.882

6.  The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.

Authors:  T Arnould; E Kim; L Tsiokas; F Jochimsen; W Grüning; J D Chang; G Walz
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

7.  Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains.

Authors:  R Sandford; B Sgotto; S Aparicio; S Brenner; M Vaudin; R K Wilson; S Chissoe; K Pepin; A Bateman; C Chothia; J Hughes; P Harris
Journal:  Hum Mol Genet       Date:  1997-09       Impact factor: 6.150

8.  Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.

Authors:  Yunxia Tao; Jun Kim; Robert W Schrier; Charles L Edelstein
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

9.  Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease.

Authors:  W E Sweeney; E D Avner
Journal:  Am J Physiol       Date:  1998-09

10.  Cellular redistribution of protein tyrosine phosphatases LAR and PTPsigma by inducible proteolytic processing.

Authors:  B Aicher; M M Lerch; T Müller; J Schilling; A Ullrich
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

View more
  16 in total

Review 1.  Regulation of ciliary motility: conserved protein kinases and phosphatases are targeted and anchored in the ciliary axoneme.

Authors:  Maureen Wirschell; Ryosuke Yamamoto; Lea Alford; Avanti Gokhale; Anne Gaillard; Winfield S Sale
Journal:  Arch Biochem Biophys       Date:  2011-04-14       Impact factor: 4.013

2.  Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin.

Authors:  Gail A Reif; Tamio Yamaguchi; Emily Nivens; Hiroyuki Fujiki; Cibele S Pinto; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-03

Review 3.  The extracellular matrix and ciliary signaling.

Authors:  Tamina Seeger-Nukpezah; Erica A Golemis
Journal:  Curr Opin Cell Biol       Date:  2012-07-19       Impact factor: 8.382

4.  Protein phosphatase 1α interacts with a novel ciliary targeting sequence of polycystin-1 and regulates polycystin-1 trafficking.

Authors:  Chong Luo; Maoqing Wu; Xuefeng Su; Fangyan Yu; David L Brautigan; Jianghua Chen; Jing Zhou
Journal:  FASEB J       Date:  2019-06-03       Impact factor: 5.191

Review 5.  Polycystins and partners: proposed role in mechanosensitivity.

Authors:  Kevin Retailleau; Fabrice Duprat
Journal:  J Physiol       Date:  2014-03-31       Impact factor: 5.182

6.  Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma.

Authors:  Vijay Walia; Todd D Prickett; Jung-Sik Kim; Jared J Gartner; Jimmy C Lin; Ming Zhou; Steven A Rosenberg; Randolph C Elble; David A Solomon; Todd Waldman; Yardena Samuels
Journal:  Hum Mutat       Date:  2014-09-10       Impact factor: 4.878

Review 7.  Adhesion GPCRs as a paradigm for understanding polycystin-1 G protein regulation.

Authors:  Robin L Maser; James P Calvet
Journal:  Cell Signal       Date:  2020-04-16       Impact factor: 4.315

Review 8.  Polycystins as components of large multiprotein complexes of polycystin interactors.

Authors:  Emily Hardy; Leonidas Tsiokas
Journal:  Cell Signal       Date:  2020-04-17       Impact factor: 4.315

9.  The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation.

Authors:  Jeffrey J Talbot; Xuewen Song; Xiaofang Wang; Markus M Rinschen; Nicholas Doerr; Wells B LaRiviere; Bernhard Schermer; York P Pei; Vicente E Torres; Thomas Weimbs
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

Review 10.  Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.

Authors:  Mitchell I Parker; Anna S Nikonova; Danlin Sun; Erica A Golemis
Journal:  Cell Signal       Date:  2019-12-09       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.